In a strategic acquisition set to advance its cell therapy capabilities, Roche Holdings, Inc. announced its acquisition of Poseida Therapeutics (PSTX) for up to $13 per share, amounting to an equity value of approximately $1.5 billion. The transaction includes $9.00 per share in cash at closing, alongside a contingent value right (CVR) of up to […]
Rivian Automotive (RIVN) announced a significant boost to its expansion efforts with a “conditional commitment” for a $6.6 billion loan from the U.S. Department of Energy (DOE). This loan, part of the DOE’s Advanced Technology Vehicle Manufacturing (ATVM) program, is intended to support Rivian’s stalled plans for a large-scale electric vehicle (EV) assembly plant near […]
